ReviewFrontiers in oncology2026
The role of robotic-assisted inguinal lymphadenectomy in vulval cancer: feasibility, peri-operative outcomes and oncological safety.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vulval cancer is a rare tumor, accounting for 3-5% of malignancies of the female reproductive system. The surgical management usually involves the radical excision of the tumor and inguinal node assessment for tumors with depth >1mm. Inguinal node dissection is usually performed as an open procedure through a 5-10cm incision in the groin area and carries a high risk of postoperative complications including wound infection, delayed wound healing, lymphocele and lymphedema which may result in prolonged hospitalization and delay in the adjuvant treatments for these patients. The role of minimal invasive surgery (MIS) in inguinal node dissection has been recently explored. Data extrapolated from melanoma and penile cancer patients showed that MIS inguinal node dissection is feasible, but it requires technical expertise and involves a steep learning curve. The aim of our study is to explore the feasibility and the oncological safety of the robotic inguinal node dissection for patients with vulval cancer, with secondary endpoint the intra- and post-operative outcomes for these patients compared to the open approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.